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a  b  s  t  r  a  c  t
Introduction:  Lower  social  class  has  higher  lung  cancer  incidence,  largely  attributable  to  higher  smoking
prevalence  among  the  lower  social  classes.  We  assessed  the  magnitude  and  time  dimension  of  potential
impact  of  targeted  interventions  on  smoking  on  socioeconomic  inequalities  in  lung  cancer.
Methods: Using  population  dynamic  modelling,  we projected  lung  cancer  incidence  up to  2050  in lowest
and  highest  socioeconomic  groups  under  two  intervention  scenarios  (annual  10%  increase  in  cigarette
prices  and  health  advertisement)  and  compared  this  to  a scenario  of  no  intervention.  For  the  analysis  we
retrieved  smoking  prevalence  data  from  the  General  Household  Survey  of England  and  Wales  between
1980  and  2006  and  cancer  incidence  data from  the  national  cancer  registry.
Results: By  2050,  the  model  projected  that lung  cancer  incidence  inequality  would  almost  double  (Inci-
dence  Rate  Ratio  (IRR)  =  4.2 in  2050  vs.  2.5  in  2005)  in men  and  slightly  decrease  (IRR  =  2.4  in  2050  vs.
2.7  in 2005)  in  women  compared  to what  was  observed  in  2005.  If annual  increase  in  cigarette  price
targeting  the  lowest  socioeconomic  group  was  implemented,  socioeconomic  inequality  in lung  cancer
incidence  in  2050  might  be largely  reduced  (IRR  =  1.5  and  1.4 among  men  and  women,  respectively).  If
in  addition  to annual  price  increase  (targeted  to  the lowest  socioeconomic  group)  health  advertisement
was  implemented  and  successfully  reduced  smoking  prevalence  in  the highest  socioeconomic  group,
the  lung  cancer  gap  between  the  socioeconomic  groups  would  be  reduced  by 78%  and  58% in men  and
women  by 2050.
Conclusion:  Even  under the  best  scenarios,  inequality  in  lung  cancer  was  not fully  eliminated  within  45
years  period.  Though  the  process  is  lengthy,  rigorous  interventions  may  reduce  the  expected  widening
of  the  future  inequalities  in  lung  cancer.  Modelling  exercise  such  as  ours  relies  heavily  on the  quality  of
the  input  data  and the  assumptions,  thus  caution  is  needed  in  interpretation  of our ﬁndings  and  should
consider  all  the  assumptions  taken  in the  analysis.. Introduction
Despite steady declines in smoking prevalence during recent
ecades, lung cancer remains the main cause of cancer death world-
ide [1]. In 2002, more than 1 million deaths were caused by lung
ancer alone [1], and in the UK, one in ﬁve cancer deaths were due
o lung cancer [2]. In developed countries where the smoking epi-
emic has reached its ﬁnal stage, the lowest socioeconomic groups
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are about twice as likely to die from lung cancer than their high-
est socioeconomic group counterparts [3]. A substantial part of this
inequality has been attributed to higher smoking prevalence in the
lower socioeconomic groups [4]. As disparities in smoking may  con-
tinue to increase, lung cancer inequalities are expected to widen in
the coming decades [3,5].
A  number of policy interventions have proved effective in reduc-
ing smoking prevalence in the lower socioeconomic groups [6,7].
Although there is controversy on the effect of cigarette price
Open access under the Elsevier OA license.increase and smoking among the different socioeconomic classes
[8,9], some studies have suggested that tobacco taxation (and resul-
tant price increase) effectively reduces smoking prevalence in the
lower socioeconomic groups [6,10]. The Royal College of Physi-
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roducts by 10% annually using tax as part of a wider strategy of
iscouraging smoking [11]. This strategy could not only help reduc-
ng smoking prevalence in the UK, but also in turn may  contribute
o diminish the socioeconomic gap in smoking prevalence and lung
ancer incidence.
In this paper, we examine the potential impact of implementing
igher tobacco price on socioeconomic inequalities in lung can-
er incidence during the coming decades. We  especially wanted
o examine the time needed to eradicate this inequality. Because in
eality many interventions are running simultaneously in a popula-
ion, therefore we also examined the impact on inequality if health
romotion against smoking were implemented [10]. This model
ill provide insight of the prospect to reduce inequality in lung
ancer where multiple interventions are being implemented. Addi-
ionally, we also examine the impact of recent changes in cigarette
moking among the highest and the lowest socioeconomic groups
n the future trend in inequality of lung cancer.
. Materials and methods
We  obtained the general household survey (GHS) [12] data on
hree categories of cigarette smoking (smokers, ex-smokers and
on-smokers) for a nationally representative population in Eng-
and and Wales between 1980 and 2006. The GHS is a continuous
urvey which has been running since 1971 except in 1997/98 when
he survey was reviewed and 1999/2000 when it was  re-developed.
t is based on a sample of the general population resident in pri-
ate (non-institutional) and collects data on approximately 9000
ouseholds and 16,000 adults aged 16 and over. To derive yearly
revalence of smokers, data for intermediate years were interpo-
ated using a cubic spline.
Socioeconomic categories were based on the occupation and
pproximated socio-economic group [13]. The occupational class
as classiﬁed on the basis of last main job, and never worker or
ong-term unemployed are classiﬁed into a distinctive group that
ere not included in our analysis. For women, the socioeconomic
roup of the household head was used. Between 1980 and 2000,
e used professionals, employers and managers to represent the
ighest socio-economic group, while the semi-skilled manual and
nskilled manual occupations represented the lowest group. In
001 the socioeconomic classiﬁcation was improved by combin-
ng information on current or last main job and employment status
.e. whether an employer, self-employed, a manager, a supervisor
r an employee. Therefore, since 2001, the highest socio-economic
roup refers to large employers and higher managerial occupations,
hile the lowest socio-economic group refers to semi-routine and
outine occupations.
One of our outcome measures was the future incidence rate
f lung cancer. Because lung cancer incidence is mainly driven
y smoking prevalence, we ﬁrstly modelled the future smok-
ng prevalence. For this purpose, we used an existing prediction
ethod, which has been described elsewhere [14]. This model cal-
ulates prevalence of smoking based on the dynamics in people
ho initiate smoking, quit smoking and those who die because
f smoking [15]. The net cessation rates (i.e. the proportional
hanges in smoking prevalence) and initiation rates according to
ex, age, socio-economic groups and period are presented in Table 1
Table 1). The predicted estimates based on the model produced a
ood to reasonable ﬁt to the observed data in 1980–2006 (R2 = 0.98
nd 0.85 for highest and lowest socio-economic group, respec-
ively). The cessation rates produced here were used in Prevent (see
elow) to calculate the future smoking prevalence as proposed by
endez to derive lung cancer incidence.
Incidence rates of lung cancer were retrieved by sex and 5-year
ge groups for the year 2005 (base year) from the ofﬁce for nationalncer 73 (2011) 268– 273 269
statistics [13]. Incidence rates for the highest and lowest socioeco-
nomic groups were calculated by weighing the general incidence
rate to the lung cancer incidence rate of the speciﬁc socioeconomic
group (either I: highest socioeconomic group or V: lowest socioe-
conomic group) as reported by Shack et al. [5].  Reported incidence
rates in the present article are age standardized using the standard
European population (ESR).
We  retrieved the following demographic data: (a) annual num-
ber of births and death rates by age and sex from 1980 to 2006;
(b) population size at January 1, 1980 for 1-year age groups by
sex; and (c) population projection up to 2050 [13,16,17].  We  did
not use socioeconomic speciﬁc demographic data because demo-
graphic projection is highly uncertain. Therefore in this paper we do
not present number of lung cancer cases by socioeconomic groups.
As for annual mortality rates by age and sex, they were corrected
for socioeconomic groups by weighing the general population rates
to mortality rates by socioeconomic group [18].
To model the impact of intervention on cancer incidence we
used Prevent. The validity of this model has been tested as
compared to the Peto method [19]. Prevent is a state-transition
simulation model that estimates the health beneﬁts in a population
due to changes in risk factor prevalence [20]. The details of calcula-
tion within Prevent are described in Appendix 1. In short, the model
ﬁrstly calculates the incidence of disease that would be observed if
no intervention to prevent smoking is implemented (autonomous
trend). In this ﬁrst part, the incidence of lung cancer is calculated
based on the current change of smoking prevalence inﬂuenced by
the current policy on tobacco smoking. Here, trend impact fraction
(TIF) is calculated and applied to cancer incidence. TIF is based on
the relative risk and past prevalence data of the risk factor (smok-
ing) [21]. We  used the relative risk for lung cancer as reported by
Gandini et al. (Risk Ratios; 9.9 among men  and 7.6 among women)
[22]. Secondly, after an intervention is speciﬁed, the model calcu-
lates the development of the potential impact fraction (PIF) due to
changes in smoking prevalence, which is caused by both the inter-
vention and the autonomous trend. The difference between the ﬁrst
and the second estimate is attributable to the intervention [23].
Prevent models the relation between risk factor exposure and
disease risk dynamically with latency (LAT) and lag time (LAG) vari-
ables. LAT is the time that is needed between changes in risk factor
and any change in cancer risk. In this study we  deﬁned the latency
time to be 5 years [24]. LAG is the time that is needed for a former
smoker to return to the risk of a non-smoker. We  set LAG to be
15 years, declining of the risk in an exponential manner [24]. This
means that after a total 20 years since the intervention took place
the risk of lung cancer of a former smoker will return to the risk of
a non-smoker.
The Tobacco Advisory Group of the Royal College of Physicians
(RCP) has proposed a yearly increase in cigarette price as one of
the strategies to eradicate smoking prevalence in the UK [11]. Here
we applied 10% yearly increase in cigarette price and assumed that
the price increase was  annually adjusted for inﬂation. In this study,
we  assumed that the price increase only decreases cigarette smok-
ing in the lower socioeconomic group [7,10,25]. We recognized the
controversies on the impact of cigarette price increase on smok-
ing in different socioeconomic groups [8].  Therefore we  examined
the impact on changing this assumption on the sensitivity anal-
ysis (further describe below). A one percentage point increase in
price was reported to decrease the demand for cigarettes by 1%
and 0.9% in men  and women from the lowest socioeconomic class
[10]. For the main analysis, we  assumed that it did not inﬂuence
the demand for cigarettes for the highest socioeconomic group
[10]. In the modelling, this means that every year the prevalence of
smokers would decrease by 10% for men  and 9% for women, in the
lower socioeconomic class. In addition to the modelling based on
the price indexing, we  also estimated the lung cancer incidence if a
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Table 1
Net cessations ratesa in England and Wales according to sex, socioeconomic group and period, 1980–2006.
Male Female
1980–1990 1991–2000 2001–2006 1980–1995 1996–2001 2002–2006
Socioeconomic group I (highest)
20–30 years 0.040 0.023 0.070 0.022 0.017 0.091
31–50  years 0.009 0.014 0.058 0.028 0.003 0.037
51+  years 0.060 0.022 0.069 0.077 0.036 0.065
Socioeconomic group V (lowest)
20–30 years 0.000 0.016 −0.015 −0.003 0.018 0.006















































socioeconomic group would reduce the inequality in lung can-
cer incidence by 58% i.e. IRR = 1.6 (with both interventions) vs. 2.4
(without intervention).
We  undertook several sensitivity analyses by varying the lag
time and the relative risk estimates (Table 2). There was little effect51+  years 0.030 0.045 
he proportional change is positive if prevalence declines or negative if prevalence
a Net cessation rate: proportional change in smoking prevalence.
igorous (yearly) health campaign against smoking was  to be imple-
ented. Anti-smoking counter-advertising has been reported to
educe the smoking prevalence among the higher socioeconomic
roups [10,26]. This model will provide insight of the prospect to
educe inequality in lung cancer where multiple interventions are
eing implemented.
.1. Sensitivity analyses
As with any prediction method, Prevent makes several assump-
ions and relies heavily on underlying input data. Therefore,
aseline data including incidence, prevalence and population data
ere derived from comparable and established resources and are
ssumed to be reliable. To examine the robustness of our results
e performed several sensitivity analyses. We  examined the effect
f assuming lag periods of 25 years (meaning that after 30 years
ince the start of the intervention the risk of lung cancer for the
x-smoker would be similar to the non-smoker); the effect of
ssuming an inﬁnite lag time (meaning that risk of ex-smokers
ould never reach that of the non-smoker); and the effect of
sing a different relative risk estimates (23.9 and 8.7 for males
nd females, respectively) [27]. Recognizing that various studies
ave reported different price elasticities, we also examined the
ffect of having a higher price elasticity in the younger age group
f the lowest socioeconomic group (those younger than 35 years
ad twice the price elasticity of those 35 years and older) [28];
he effect on lung cancer inequality if the highest socioeconomic
roup were also responsive to price change (the higher socioeco-
omic group was reported to have half of the price elasticity of the
owest socioeconomic group) [8];  and the effect of using different
rice elasticity estimates (0.45% for men  and 0.41% for females)
8].
. Results
Fig. 1 illustrates the projected proportion of cigarette smok-
rs according to socioeconomic group and sex. In 1980, 69% and
6% higher smoking prevalence was observed among the male and
emale lower socioeconomic group as compared to the highest
ocio-economic group. The relative difference increased markedly
ver time and was observed in the projections. In the 1980s smok-
ng prevalence was 50–70% higher in the lowest socioeconomic
roup. In 2050 we expected the lowest socioeconomic group (men)
ould be four times more likely to smoke as compared to the most
fﬂuent group.
Table 1 presents the net annual cessation rates for three age
roups according to sex, socioeconomic group and time period. In
eneral, net cessation rates were higher among the highest socioe-
onomic group as compared to the lower socioeconomic group. In
he last period (2002–2006), we estimated high age-speciﬁc quit-
ing rates ranging from 5.8% to 9.0% annually among the highest0.027 0.038 0.056
ses.
socioeconomic group and only 0.5–6.0% among the lower socioe-
conomic group.
Fig. 2a shows the lung cancer incidence rate for the highest
and lowest socio-economic groups for males as projected by the
model with and without intervention among men  in the period
2005–2050. In 2005, the standardized lung cancer rate in the low-
est socioeconomic group was 2.5 times higher than the rate in the
highest socioeconomic group. For both socioeconomic groups, lung
cancer incidence is predicted to decrease, but more so for the high-
est socioeconomic group. Under the scenario of no intervention,
the model predicts that lung cancer inequality will double by 2050
(Incidence Rate Ratio (IRR) = 4.2 in 2050). The model projected that
a yearly increase in cigarette price would decrease the socioeco-
nomic gap in lung cancer incidence by 86% in 2050 i.e. IRR = 1.5
(with price increase) vs. 4.2 (without intervention). If anti-smoking
counter-advertising were implemented, lung cancer incidence rate
among the highest socioeconomic group is estimated to decrease
to 14.1 per 100,000. This would diminish the impact of the price
indexing in inequality: 78% of inequality will be reduced by 2050
IRR = 1.7 (with both interventions) vs. 4.2 (without intervention).
Fig. 2b presents the same projection of lung cancer incidence but
for women. Under the scenario of no intervention, socioeconomic
group inequalities in lung cancer incidence will slightly decrease
in 2050 (IRR = 2.4 and in 2005 IRR = 2.7). If annual increases in
cigarette prices were introduced, inequalities in lung cancer inci-
dence would be reduced by 74% in 2050 (IRR = 1.4). If anti-smoking
counter-advertising was  also included in the model, the lung cancer
incidence rate among the highest economic group would decrease
to 9.9 from the predicted 11.6 per 100,000 cases in 2050. Imple-
menting an intervention targeted to both the lowest and the highestFig. 1. Predicted proportion of smokers according to socioeconomic group and sex
in  1980–2050.
I. Soerjomataram et al. / Lung Ca
Fig. 2. Predicted lung cancer incidence (European Standardised Rate, ESR) in Eng-













inequalities in smoking. However, a current review on popula-
T
S
Intervention (intervention: yearly 10% price increase for low socioeconomic group
nd  yearly health advertisement for high socioeconomic group). (A) Male; (B)
emale.
f varying the lag time on the lung cancer inequality i.e. the inci-
ence rate ratio between the lowest and the highest socioeconomic
roup if the two intervention scenarios (price increase and health
dvertisement) was 1.7 in males and 1.6 in females in 2050 if 30
ears lag was used (similar to the baseline scenario with 15 years lag
ime). If we assumed that the risk of ex-smokers never reached that
f the non-smoker, than the inequality the gap would be slightly
maller than the baseline estimate (IRR = 1.4 for both genders). If




Model A (Baseline): 20 years latency time, intervention for both SES groupsa
Model  B: 30 years latency time, intervention for both SES groupsa
Model  C: lung cancer risk in ex-smokers never equal to non-smoker, intervention for b
Model  D: relative risk 23.9 (male) and 8.7 (female) instead of 9.7 and 8.7 in Model A, in
Model  E: younger age group more price sensitive (price elasticity <35 years: 2% (men) a
and  0.9% in Model A), intervention for both SES groupsa
Model  F: highest SES group also price sensitive (price elasticity in highest SES 0.5% (me
of  0 in Model A), intervention for both SES groupsa
Model  G: different price elasticities for lowest SES group (0.45% for men  and 0.41% for w
in  Model A), intervention for both SES groupsa
R: Incidence Rate (European Standardized Rate, per 100,000); IRR: Incidence Rate Ratio;
a Price increase affecting the lowest socioeconomic group and health advertisement afncer 73 (2011) 268– 273 271
the inequality in lung cancer would decrease slightly more than the
baseline estimate with IRR of 1.6. As for changing the price elasticity
estimates, the largest difference (as compared to the main analysis)
was  found if the price elasticity was  reduced by half for the low-
est socioeconomic group. Other changes i.e. highest socioeconomic
groups being responsive to price change or the younger age group
being more responsive that other age groups, did not change the
results of the modelling as compared to the main model.
4. Discussion
Our study illustrates the potential and the time needed to reduce
socioeconomic inequalities in lung cancer in England and Wales
using a targeted smoking intervention policy. If the current course
of smoking continued, we projected a widening of inequality in lung
cancer as has been expected by others [3].  Under the most rigorous
intervention i.e. annual price increase was implemented, the dis-
parity in lung cancer was  reduced but not eradicated. Among men,
the scenario of a yearly price increase would only eliminate the
socioeconomic gap in lung cancer by 86% in 2050. Among women,
74% of socioeconomic relative inequalities in lung cancer might
be reduced after 45 years. If another intervention that inﬂuences
prevalence among the higher socioeconomic groups e.g. health pro-
motion efforts are included in the model, closing the gap is further
delayed.
As predicted by others [3,29],  we projected an increase in lung
cancer inequality in men  in the future in the UK. Although smoking
has been decreasing in all socioeconomic groups, we  still observed
higher uptake among the adolescents in the lower socioeconomic
group. Furthermore, they are also more likely to become regular
smoker and less likely to stop smoking [30]. These all contribute to
the increasing gap in smoking among men, that in the future will
be reﬂected in the inequality in lung cancer rates.
In reality, many intervention programs are currently in place
in the UK and these will affect our ﬁndings [31]. New legislations
have also been implemented such as the smoke-free UK, which may
further increase quit rates [32]. If the higher socioeconomic group
responds the most to an intervention, it may  potentially increasetion tobacco control strategies showed little evidence of adverse
effects on inequality from population intervention programs such
as restrictions in workplaces, public places or schools, restrictions
of sales to minors, restrictions on tobacco advertisement and health
SES Male, 2040 Female, 2040
IR IRR IR IRR
Highest 14.1 1 10.0 1
Lowest 24.2 1.7 16.0 1.6
Highest 13.5 1 9.6 1
Lowest 22.8 1.7 15.6 1.6
oth SES groupsa
Highest 15.9 1 11.11 1
Lowest 22.3 1.4 15.5 1.4
tervention for both SES groupsa
Highest 7.6 1 9.3 1
Lowest 12.1 1.6 14.4 1.6
nd 1.8% (women) instead of 1% Highest 14.1 1 10.0 1
Lowest 23.5 1.7 15.7 1.6
n) and 0.45% (women) instead Highest 14.1 1 10.2 1
Lowest 24.2 1.7 16.0 1.6
omen instead of 1% and 0.9% Highest 14.1 1 10.0 1
Lowest 31.7 2.2 26.6 2.7
 SES: socioeconomic status.
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arning on tobacco products [33]. Therefore the major tobacco
ontrol steps that have been taken by the UK government, e.g.
edia advertisement ban, smoking cessation services, clean indoor
ir laws and earmarking may  have resulted in higher cessation rates
han what we have predicted [34]. But this might be equally true for
ifferent socio-economic groups [7,31].  Although intuitively, work-
lace smoking bans in places with a high concentration of workers
rom a lower socioeconomic class would impact smoking more in
his group, overall the impact of this intervention on daily cigarette
moked is the same in different socioeconomic groups [7].
The positive impact of cigarette price increases on smoking may
e offset by increases in cigarette smuggling [35]. In the UK it is
stimated that about 13% of cigarettes in 2005–2006 are smuggled
36]. Because the lower socioeconomic groups more often con-
ume smuggled cigarettes, we may  have overestimated the impact
f cigarette prices on inequalities in smoking prevalence and lung
ancer. However, over the last decades, the UK government seems
o have been successful in reducing the prevalence of contraband
obacco which may  continue in the future [36]. This study therefore
lso points to the importance of comprehensive smoking inter-
ention strategies i.e. reducing the availability of smuggled and
ounterfeit tobacco, optimising smoking cessation services, inter-
ational advocacy [11].
We used the price elasticity of demand for cigarettes from a
tudy based on data from 1972 to 1990 as the impact of the inter-
ention [10]. Our model assumed that the impact of price indexing
n smoking prevalence is the same regardless of the price of
igarettes in each time period. However, the impact of price index-
ng on smoking prevalence may  decrease as background cigarette
rices increase [8].  On the other hand, the impact of price increases
n smoking prevalence may  increase as background cigarette price
ncreases, because a 1% increase at a high price levels is in absolute
erms larger than at low price levels. At this point, there is insuf-
cient evidence on how the impact of cigarette price increases on
moking prevalence varies across different background cigarette
rices. Furthermore, others have also reported different estimates
n price elasticity by gender, age group or socioeconomic group
28,33]. In our sensitivity analysis we examined the impact of
arying price elasticity in different age groups and socioeconomic
tatus. Increasing price responsiveness among the younger age
roup did not result in different lung cancer inequalities in 2050
s compared to the base model where all ages have the same price
lasticity. This is probably because changes in smoking prevalence
mong the younger age groups would only affect lung cancer inci-
ence in a very long time perspective, beyond the end of this study
eriod (2050). The largest difference to the main analysis was  found
f other estimate of price elasticity was used [8].  Thus interpreta-
ion of this study should consider all assumptions that were taken
n the analysis. Another limitation that should be mentioned is the
act that we used self-reported smoking. Yet studies have shown
hat the validity of self-reported smoking is high and similar by
ocioeconomic status [37].
We projected a marked decline in the proportion of smokers in
ll groups that we studied except for males of the lower socioe-
onomic class. This is due to the low cessation rates (0.5% annual
ecrease) in the middle aged men. As we reported, the ﬁt of our
redicted model for smoking prevalence in this group is only rea-
onable. Yet, the data showed that between 2000 and 2006, the
roportion of smokers in the middle age group (30–40) in men
mong the lowest socioeconomic class in our study was  40% in 2000
nd 43% in 2006. Secondly, the analysis was restricted to groups I
nd V. Because of changes in the nature of works and occupation in
he late twentieth century, group V is gradually becoming smaller
ver time i.e. in 1980 23% of the survey population was in this group
ompared to 19% in 2001 [12]. For this reason the national statis-
ics ofﬁce changed the Socioeconomic classiﬁcation in 2001 [38].
[
[ncer 73 (2011) 268– 273
For continuity reasons, we  kept the analysis to this group. Further,
increasing cigarette price by 10% annually is politically challenging
[39]. Yet, in the UK there has been on average 5% annual increase in
real price in cigarette [34]. From public health perspective it is ulti-
mately more important how affordable cigarette price is. Yet in the
UK cigarettes are still more affordable than they were in the 1960s
[40]. Therefore there is ample room for price increase in retail price
of cigarette.
Our study illustrated the future of inequality in lung cancer
in UK and projected an increasing gap between the wealthy and
the poor. A long time perspective is needed to decrease socioe-
conomic disparities in lung cancer rates. Yet, slow, rigorous and
targeted interventions may  reduce the expected widening of the
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